Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice. This is the first time that genome editing, which precisely targets and repairs a genetic defect, has been done in a living animal and achieved clinically meaningful results.
Genome editing, a next step in genetic therapy, corrects hemophilia in animals
Post a Comment
If the post you are commenting on is more than 30 days old, your comment will have to await approval before being published. Rest assured, however, that as long as it is not spam, it will be published in due time.